Rapid weight loss from GLP-1 receptor agonists often includes substantial reductions in skeletal muscle mass alongside fat loss

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.